William Werbel, MD
Enriched profileAssociate Professor of Medicine, Division of Infectious Diseases · Johns Hopkins University School of Medicine
William Werbel is Associate Professor of Medicine, Division of Infectious Diseases at Johns Hopkins University School of Medicine. OpenAlex indexes 159 publications with 6,491 citations (h-index 35); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 18 Oct 2026
William Werbel, M.D., is Associate Professor of Medicine, Division of Infectious Diseases at Johns Hopkins University School of Medicine. The public record shows 159 publications with 6,491 citations (h-index 35), centered on SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Vaccine Coverage and Hesitancy. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies, 2 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · Open forum infectious diseases
- Top research focus: SARS-CoV-2 and COVID-19 Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 47 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 68.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 18 Oct 2026
2 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
- AstraZeneca Pharmaceuticals LPProgram year20232 payments
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
56.9%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor32.1%Tivicay100%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor24.8%Triumeq100%Part D<11 patientsCardiovascular
33%Statin22%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker11%Amlodipine-Atorvastatin100%Part D<11 patientsNervous system
10.1%SSRI10.1%Escitalopram Oxalate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients
Johns Hopkins University
FY2026$1,454,101R01AI190359 - Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients
Johns Hopkins University
FY2025$1,442,898R01AI190359 - The Landscape of Serious Infections following Kidney Transplantation in People Living with HIV
Johns Hopkins University
FY2025$129,187K23AI157893
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Durability of Respiratory Syncytial Virus Antibodies After Vaccination in Immunosuppressed Persons.
Open forum infectious diseases
Article2026 - Beyond the Blood: Insights Into Mucosal Immunity Among SARS-CoV-2-Vaccinated Kidney Transplant Recipients.
Transplant infectious disease
Editorial2026 - Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States.
Clinical infectious diseases
Article2026 - Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus.
Transplant infectious disease
Article2025
Most-cited works
by citation count (OpenAlex)- 01Foot strike patterns and collision forces in habitually barefoot versus shod runnersArticle1,417 citations2010
- 02Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsArticle959 citations2021
- 03
- 04
- 05Early impact of COVID-19 on transplant center practices and policies in the United StatesArticle243 citations2020
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/william-werbel-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
atc.digitellinc.com/b/sp/william-werbel-28530
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atc.digitellinc.com ↗ - Other
medicine-matters.blogs.hopkinsmedicine.org/2025/07/werbel-receives-career-development-award
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine-matters.blogs.hopkinsmedicine.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- PhD in Clinical Investigation
Johns Hopkins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emergingpathogens.jhmi.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital